Announcements
Journal: Frontiers in Bioscience-Landmark
Submission deadline:
31 December 2019
Special Issue Editors
Jonathan S. Duke-CohanPh.D., Dana-Farber Cancer Institute, Medical Oncology, JF517, 450 Brookline Avenue, Boston MA 02215Interests: 70 publications, 7 grants, Editor of Frontiers in Bioscience- Aleksi SedoM.D., Ph.D., Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology of the First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech RepublicInterests: >50 publications, grants, Editor of Frontiers in Bioscience
Keywords
Blood and Bone Marrow
Cancer
Cardiovascular System
Cell Biology
Development
Endocrine System
Genes and Genetics
Immune System
Inflammatory Responses
Nervous System
Nutrition
Molecular Biology
Signaling
Skin and Integument
Therapeutics
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
Published Paper (24 Papers)
- ReviewGCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyondBarbora Vorlova, Tomas Knedlik, Jan Tykvart, Jan KonvalinkaFront. Biosci. (Landmark Ed) 2019, 24(4), 648–687; https://doi.org/10.2741/4742(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)97Downloads6Citations193Views
- ReviewAnti-diabetic treatment leads to changes in gut microbiomeEleni Xourgia, Athanasia Papazafiropoulou, Nikolaos Papanas, Andreas MelidonisFront. Biosci. (Landmark Ed) 2019, 24(4), 688–699; https://doi.org/10.2741/4743(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)129Downloads14Citations215Views
- Review
Fibroblast activation protein in liver fibrosis
Angelina J. Lay, Hui E. Zhang, Geoffrey W. McCaughan, Mark D. GorrellFront. Biosci. (Landmark Ed) 2019, 24(1), 1–17; https://doi.org/10.2741/4706(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)635Downloads41Citations1020Views - Review
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
Kei Ohnuma, Ryo Hatano, Eriko Komiya, Haruna Otsuka, ... Chikao MorimotoFront. Biosci. (Landmark Ed) 2018, 23(9), 1754–1779; https://doi.org/10.2741/4671(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)78Downloads22Citations152Views - Review
Targeting fibroblast activation protein in cancer – Prospects and caveats
Petr Busek, Rosana Mateu, Michal Zubal, Lenka Kotackova, Aleksi SedoFront. Biosci. (Landmark Ed) 2018, 23(10), 1933–1968; https://doi.org/10.2741/4682(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)710Downloads100Citations1191Views - Article
Dipeptidyl peptidase 8 and 9 - guilty by association?
Melissa R. Pitman, Melanie L. Sulda, Bryone Kuss, Catherine A. AbbottFront. Biosci. (Landmark Ed) 2009, 14(10), 3619–3633; https://doi.org/10.2741/3476(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)17Downloads19Citations34Views - ArticleInhibiting dipeptidyl peptidase activity partially ameliorates colitis in miceRoger Yazbeck, Gordon S Howarth, Mark S Geier, Hans-Ulrich Demuth, Catherine A AbbottFront. Biosci. (Landmark Ed) 2008, 13(18), 6850–6858; https://doi.org/10.2741/3193(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)25Downloads38Citations34Views
- ArticleInflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitorsUte Bank, Ulrich R.M Bohr, Dirk Reinhold, Uwe Lendeckel, ... Michael TägerFront. Biosci. (Landmark Ed) 2008, 13(10), 3699–3713; https://doi.org/10.2741/2960(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)18Downloads25Citations27Views
- ArticleDipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetesPeter R Flatt, Clifford J Bailey, Brian D GreenFront. Biosci. (Landmark Ed) 2008, 13(10), 3648–3660; https://doi.org/10.2741/2956(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)30Downloads61Citations123Views
- Article
Purification and characterization of a dipeptidyl peptidase 9-like enzyme from bovine testes
Véronique Dubois, Anne-Marie Lambeir, Pieter Van der Veken, Koen Augustyns, ... Ingrid De MeesterFront. Biosci. (Landmark Ed) 2008, 13(9), 3558–3568; https://doi.org/10.2741/2949(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)30Downloads21Citations52Views - ArticleNon-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell functionSabine Wrenger, Jurgen Faust, Carmen Mrestani-Klaus, Wolfgang Brandt, ... Dirk ReinholdFront. Biosci. (Landmark Ed) 2008, 13(9), 3194–3201; https://doi.org/10.2741/2920(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)2Downloads1Citations10Views
- ArticleDPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetesCarolyn F Deacon, Richard D Carr, Jens J HolstFront. Biosci. (Landmark Ed) 2008, 13(5), 1780–1794; https://doi.org/10.2741/2799(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)13Downloads63Citations31Views
- ArticleRole of CD26/dipeptidyl peptidase IV in human T cell activation and functionKei Ohnuma, Nozomu Takahashi, Tadanori Yamochi, Osamu Hosono, ... Chikao MorimotoFront. Biosci. (Landmark Ed) 2008, 13(6), 2299–2310; https://doi.org/10.2741/2844(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)62Downloads93Citations241Views
- Article
Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?
Petr Busek, Jarmila Stremenova, Aleksi SedoFront. Biosci. (Landmark Ed) 2008, 13(6), 2319–2326; https://doi.org/10.2741/2846(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)28Downloads19Citations89Views - ArticleRoles of molecules involved in epithelial/mesenchymal transition during angiogenesisGiulio GhersiFront. Biosci. (Landmark Ed) 2008, 13(6), 2335–2355; https://doi.org/10.2741/2848(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)8Downloads11Citations32Views
- ArticleDP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosisDirk Reinhold, Ute Bank, Michael Täger, Siegfried Ansorge, ... Stefan BrockeFront. Biosci. (Landmark Ed) 2008, 13(6), 2356–2363; https://doi.org/10.2741/2849(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)14Downloads47Citations46Views
- ArticleThe ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseasesAnja Thielitz, Siegfried Ansorge, Ute Bank, Michael Tager, ... Dirk ReinholdFront. Biosci. (Landmark Ed) 2008, 13(6), 2364–2375; https://doi.org/10.2741/2850(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)12Downloads32Citations33Views
- ArticleDipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylationCarolyn McGuinness, Umadevi V. WesleyFront. Biosci. (Landmark Ed) 2008, 13(7), 2435–2443; https://doi.org/10.2741/2856(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)4Downloads31Citations19Views
- Article
Fibroblast activation protein and chronic liver disease
Xin Maggie Wang, Tsun-Wen Yao, Naveed A. Nadvi, Brenna Osborne, ... Mark D. GorrellFront. Biosci. (Landmark Ed) 2008, 13(8), 3168–3180; https://doi.org/10.2741/2918(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)54Downloads50Citations164Views - Article
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy B. Campbell, Hal E. BroxmeyerFront. Biosci. (Landmark Ed) 2008, 13(5), 1795–1805; https://doi.org/10.2741/2800(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)6Downloads30Citations23Views - ArticleSDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26Martin Hildebrandt, Richard SchabathFront. Biosci. (Landmark Ed) 2008, 13(5), 1774–1779; https://doi.org/10.2741/2798(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)7Downloads10Citations21Views
- ArticleDipeptidyl peptidase IV inhibitors and diabetes therapyChristopher H.S. McIntoshFront. Biosci. (Landmark Ed) 2008, 13(5), 1753–1773; https://doi.org/10.2741/2797(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)9Downloads50Citations95Views
- ArticleThe role of CD26/dipeptidyl peptidase IV in cancerPamela A. Havre, Masako Abe, Yasuyo Urasaki, Kei Ohnuma, ... Nam H. DangFront. Biosci. (Landmark Ed) 2008, 13(5), 1634–1645; https://doi.org/10.2741/2787(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)89Downloads155Citations506Views
- ArticleDipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptorMario Gonzalez-Gronow, Steven Kaczowka, Govind Gawdi, Salvatore V. PizzoFront. Biosci. (Landmark Ed) 2008, 13(5), 1610–1618; https://doi.org/10.2741/2785(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)18Downloads37Citations30Views